ERYTECH PHARMA S.A.

(ERYP)
  Rapport
Real Time Euronext Paris  -  17:35 08-08-2022
1.218 EUR   +0.66%
05/08Europese ADR's bewegen lager in de vrijdaghandel
MT
04/08Europese ADR's stijgen in de donderdaghandel
MT
03/08Europese ADR's schommelen hoger in de woensdaghandel
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
OfficiŽle publicaties
30/06/22Monthly statement on outstanding equity shares and voting rights 
30/06/22Monthly statement on outstanding equity shares and voting rights 
24/06/22Press Release 
24/06/22Press Release 
24/06/22Proxy Statments 
24/06/22Proxy Statments 
31/05/22Monthly statement on outstanding equity shares and voting rights 
31/05/22Monthly statement on outstanding equity shares and voting rights 
24/05/22Press Release 
24/05/22Press Release 
18/05/22Monthly statement on outstanding equity shares and voting rights 
18/05/22Mixed general Shareholders meeting notice 
12/05/221st quarter results 
12/05/221st quarter results 
30/04/22Monthly statement on outstanding equity shares and voting rights 
30/04/22Monthly statement on outstanding equity shares and voting rights 
27/04/22SEC Filing 20 F 
27/04/22Report 
13/04/22Crossing thresholds 
31/03/22Monthly statement on outstanding equity shares and voting rights 
31/03/22Monthly statement on outstanding equity shares and voting rights 
15/03/22SEC Filing 6K-4 
11/03/22Annual results 
11/03/22Annual results 
28/02/22Monthly statement on outstanding equity shares and voting rights 
28/02/22Monthly statement on outstanding equity shares and voting rights 
15/02/22Report 
31/01/22Monthly statement on outstanding equity shares and voting rights 
31/01/22Monthly statement on outstanding equity shares and voting rights 
27/12/21Crossing thresholds 
14/12/21Report 
30/11/21Monthly statement on outstanding equity shares and voting rights 
30/11/21Monthly statement on outstanding equity shares and voting rights 
15/11/213rd quarter results 
15/11/213rd quarter results 
30/09/21Monthly statement on outstanding equity shares and voting rights 
30/09/21Monthly statement on outstanding equity shares and voting rights 
22/09/21Half-year report 
21/09/21Half-year results 
21/09/21Half-year results 
20/09/21SEC Filing 6K-2 
31/08/21Monthly statement on outstanding equity shares and voting rights 
30/06/21Monthly statement on outstanding equity shares and voting rights 
30/06/21Monthly statement on outstanding equity shares and voting rights 
25/06/21Proxy Statments 
25/06/21Proxy Statments 
31/05/21Monthly statement on outstanding equity shares and voting rights 
31/05/21Monthly statement on outstanding equity shares and voting rights 
19/05/21Crossing thresholds 
19/05/21Mixed general Shareholders meeting notice 
12/05/21Crossing thresholds 
12/05/21Crossing thresholds 
12/05/21Crossing thresholds 
12/05/21Crossing thresholds 
12/05/21Crossing thresholds 
12/05/21Crossing thresholds 
05/05/211st quarter results 
05/05/211st quarter results 
30/04/21Monthly statement on outstanding equity shares and voting rights 
30/04/21Public takeover bid 
29/04/21Report 
15/04/21Crossing thresholds 
09/04/21Crossing thresholds 
31/03/21Monthly statement on outstanding equity shares and voting rights 
31/03/21Crossing thresholds 
12/03/21Crossing thresholds 
08/03/21Annual results 
08/03/21Report 
08/03/21SEC Filing 20 F 
28/02/21Monthly statement on outstanding equity shares and voting rights 
28/02/21Monthly statement on outstanding equity shares and voting rights 
02/02/21Crossing thresholds 
31/01/21Monthly statement on outstanding equity shares and voting rights 
31/01/21Monthly statement on outstanding equity shares and voting rights 
12/01/21Crossing thresholds 
1  2Volgende
Volgende evenement op ERYTECH PHARMA S.A.